Related Experiment Video
Updated: Mar 1, 2026

Medium Preparation for the Cultivation of Microorganisms under Strictly Anaerobic/Anoxic Conditions
Published on: August 15, 2019
Development of novel microbial synthetic consortia for the production of antimicrobial fermentates containing
Maria Florencia Bambace1, Ker Sin Ng1, Kirsten Wiborg Jensen1
1Department of Biological and Chemical Engineering, Aarhus University, Aarhus, Denmark.
Abstract:
Short- and medium chain carboxylic acids (SCCA/MCCA) are natural antimicrobials produced by fermentation and chain elongation, but currently only a few SCCA/MCCA are used in food-related applications. With the aim to diversify the SCCA/MCCA profile of fermentates for biopreservation, we designed bioprocesses employing bacterial or multi-kingdom consortia to produce caproate-containing fermentates using a targeted cross-feeding strategy. We combined Limosilactobacillus reuteri, Clostridium kluyveri, and Saccharomyces cerevisiae, and quantified substrates utilization and metabolites. The antimicrobial activity of SCCA/MCCA and fermentates was analysed in vitro and in a meat model system. In a first bioprocess, the addition of ethanol (EtOH) initiated caproate formation by the bacterial consortium with levels of 63.9 mM (7.4 g L-1) after 22 days. Next, we run two shorter bioprocesses (12 days) and more caproate (28.9 mM, 3.4 g L-1) was produced if EtOH was regularly added than without EtOH supplementation (21.7 mM, 2.5 g L-1). When S. cerevisiae was included, 37.9 ± 11.4 mM (4.4 g L-1) caproate was formed without EtOH addition. Beyond the intended cross-feeding activity, consortia produced and re-metabolised mannitol and glycerol. Lactate and caproate were the major carboxylic acids in fermentates. Caproate inhibited bacteria, yeast and molds at pH 4.5 and 6.5 in vitro, while lactate and caproate acted synergistically in minced meat. Fermentates conferred antimicrobial activity against indicator microbes mostly at pH 4.5 and to a lesser extent at pH 6.5. In this study we successfully designed a consortium to produce caproate. We provide evidence that caproate-containing fermentates had strong antimicrobial activity, and our results indicate the complexity of metabolic interactions that occurred within consortium members. KEY POINTS: • Design of a self-contained bioprocess with multi-kingdom consortium. • Cross-feeding of bacteria and yeast to produce caproate fermentates. • Fermentates containing caproate inhibited bacteria, yeast and mold growth.
Related Concept Videos
Microbial Fermentation
Microorganisms in Agriculture and Food industry
Methods for Controlling Microbial Growth
Fermentation
Fermentation is a type of metabolic process that occurs in the absence of oxygen, where organic molecules such as glucose are broken down to produce energy. During this process, the...
Biosynthesis in Bacteria

